Trial description:
A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects with Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance after Allogeneic Haematopoietic Stem Cell Transplantation
Contact name:
Dr Charles Crawley
Trial start date:
Thursday, December 19, 2019
Trial end date:
Saturday, December 31, 2022
Trial tumour type:
Haematological
Show on Radiotherapy:
No
